LLY · News · 20261030N
Product Launch - Foundayo
ELI LILLY & Co · 2026-10-30 · Importance 34 · Surprise 42 · In source text
Lilly continued the global rollout of Foundayo, launching it in the U.K., Mexico, and Saudi Arabia for people with obesity. The company also launched it in Mexico for people with type 2 diabetes. The report does not provide launch dates, sales expectations, or market-specific financial estimates.
Key facts
- Eli Lilly continued the global rollout of Foundayo, launching it in the U.K., Mexico and Saudi Arabia for people with obesity, and in Mexico for people with type 2 diabetes. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | contingent | — | Eli Lilly continued the global rollout of Foundayo, launching it in the U.K., Mexico and Saudi Arabia for people with obesity, and in… |